Form 4: Humana Executive Timothy S. Huval Reports Stock Transactions
SEC Form 4 Filing
Humana's Chief Administrative Officer, Timothy S. Huval, reported the vesting of restricted stock units and the subsequent sale of shares to cover tax liabilities.
Summary
- Timothy S. Huval, Chief Administrative Officer of Humana Inc., filed a Form 4 detailing changes in his beneficial ownership of company stock.
- The transactions occurred on December 15, 2024, and involved the vesting of restricted stock units and the sale of shares to cover tax obligations.
- Huval acquired 362 and 343 shares of Humana common stock through the vesting of restricted stock units.
- He also disposed of 247, 165, and 156 shares of common stock at a price of $271.675 per share to cover tax liabilities.
- Following these transactions, Huval beneficially owns 11,884 shares of Humana common stock directly.
- Huval also holds various stock options with exercise prices ranging from $307.965 to $510.2425, exercisable between 2026 and 2031.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as the transactions are routine and expected. There is no indication of any negative sentiment or concern.
Positives
- The vesting of restricted stock units indicates that Huval is meeting performance criteria set by the company.
- The transactions are a normal part of executive compensation and do not indicate any negative sentiment.
Negatives
- The sale of shares, while for tax purposes, does reduce Huval's direct shareholding in the company.
Risks
- There are no immediate risks apparent from this filing.
- However, large sales of shares by executives could potentially signal a lack of confidence in the company's future performance if they were to occur in the future.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It does not indicate any specific trend or event within the healthcare industry.
Comparison to Industry Standards
- Executive stock transactions are a standard practice in publicly traded companies, including those in the healthcare sector.
- Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also have executives who regularly report similar transactions.
- The vesting schedules and option grants are typical forms of executive compensation.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they are routine and do not significantly alter the ownership structure.
- The transactions do not have any direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/25/2019 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three increments from 02/25/20 to 02/25/22. |
| 02/24/2020 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/24/21 to 2/24/23. |
| 02/22/2021 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/22/22 to 2/22/24. |
| 02/21/2022 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/21/23 to 2/21/25. Restricted stock units granted, 33% vesting on 12/15/22, 12/15/23, and 12/15/24. |
| 02/24/2023 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/24/24 to 2/24/26. Restricted stock units granted, 33% vesting on 12/15/23, 12/15/24, and 12/15/25. |
| 02/21/2024 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/21/25 to 2/21/27. |
| 12/15/2024 | Date of stock transactions including vesting of restricted stock units and sale of shares for tax liabilities. |
| 12/17/2024 | Date of filing of the Form 4. |
Keywords
Humana, stock options, restricted stock units, Form 4, insider trading, executive compensation, share ownership, Timothy S. Huval
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.